Skip to main content

Table 1 Summary of the results of laboratory findings on presentation

From: Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report

Laboratory investigation

Result

Reference range

Hematological profile

Hemoglobin (g/dL)

11.4

13.0–18.0

White blood cell (1000/μL)

9.8

4.0–11.0

Platelet (1000/μL)

448

140–450

Neutrophils (%)

75.4

40–60

Lymphocytes (%)

11.0

20–40

Hepatic profile

Total bilirubin (mg/dL)

1.3

0.2–1.2

Albumin (g/dL)

4.0

3.4–5.0

Alkaline phosphatase (U/L)

150

46–116

γ-Glutamyltransferase (U/L)

49

15–85

Alanine transferase (U/L)

2,411

14–63

Aspartate transferase (U/L)

2,466

15–37

Coagulation profile

Prothrombin time (s)

>120

12.9–15.9

Partial thromboplastin time (s)

120

25.6–42.3

International normalized ratio

>15.8

0.8–1.1

Inflammatory profile

C-Reactive protein (mg/dL)

<0.10

0.10–0.50

Lactic acid (mmol/L)

19.7

0.5–2.2

Ferritin (ng/ml)

165.2

4.6–204.0

Serology profile

Hepatitis A IgM antibody

Negative

Negative

Hepatitis B core antibody

Negative

Negative

Hepatitis B surface antibody

Negative

Negative

Hepatitis C virus antibody

Negative

Negative

Ebstein-Barr virus IgM antibody

Negative

Negative

Cytomegalovirus IgM antibody

Negative

Negative

Human immunodeficiency virus antibody

Negative

Negative

Autoimmune profile

Antimitochondrial antibody

Negative

Negative

Antinuclear antibody

Negative

Negative

Anti-liver/kidney microsomal antibody

Negative

Negative

Anti-smooth-muscle antibody

Negative

Negative

Toxicology profile

Acetaminophen

Negative

Negative

Tetrahydrocannabinol

Negative

Negative

Benzodiazepines

Negative

Negative